Feb 5 2011
Palomar Medical Technologies, Inc. (Nasdaq:PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, announced today the launch of the Acleara™ acne clearing system at the 69th Annual Meeting of the American Academy of Dermatology (AAD) in New Orleans, Louisiana, from February 5th through February 7th.
The Acleara acne clearing system uses broad band light and suction to treat mild to moderate acne including acne vulgaris, comedonal and pustular acne. With the Acleara system, practitioners can treat a full face in less than 15 minutes with no numbing or cooling gels and no anesthetic costs.
Acleara provides deep cleaning of pores by extracting accumulated sebaceous material, and provides targeted heating of sebaceous glands. The light activates endogenous porphyrins to destroy P. acnes and reduces sebum production through photodynamic action.
According to Dr. Robert Berger, a practicing Dermatologist from Waldorf, MD and an Associate Professor of Dermatology from Johns Hopkins School of Medicine, regarding the Acleara system, "I have performed over 15,000 treatments over 5 years using a number of different technologies to treat acne. The Acleara system has proven more effective, less painful and it delivers superior results as compared to any previous technologies I have tried in treating active acne."
Joseph P. Caruso, Chief Executive Officer, commented, "We are very excited about this product launch. It is a fantastic addition to our robust family of products and allows us to address the enormous acne market. The American Academy of Dermatology reports that Acne vulgaris is the most common skin condition in the United States. Up to 50 million Americans have acne and 85 percent of all U.S. teenagers have acne. The Acleara system offers physicians advanced technology to both deep clean and treat the skin."
Mr. Caruso continued, "Many who suffer from acne cannot tolerate or do not want to have their acne treated by drugs. The Acleara system is an excellent alternative for consumers and physicians alike."
SOURCE Palomar Medical Technologies Inc.